Genomma Lab Internacional SAB 

$0.7222
48
+$0.00+0%Friday 16:59

Statistics

Day High
0.7296
Day Low
0.7296
52W High
1.08
52W Low
0.685
Volume
4,000
Avg. Volume
8,137
Mkt Cap
722.2M
P/E Ratio
9.3
Dividend Yield
6.13%
Dividend
0.04

Upcoming

Dividends

6.13%Dividend Yield
Sep 2026
$0.01
Jun 2026
$0.01
Mar 2026
$0.01
Dec 2025
$0.01
Sep 2025
$0.01
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
2.1%
1Y Growth
8.38%

Earnings

Oct 21Expected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
0.02
0.03
0.03
0.04
Expected EPS
0.0215631
Actual EPS
N/A

Financials

8.95%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
1.15BRevenue
103.21MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow GNMLF. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Johnson & Johnson
JNJ
Mkt Cap617.01B
Johnson & Johnson operates in the pharmaceuticals and consumer health sectors, directly competing with Genomma Lab's range of over-the-counter and personal care products.
Procter & Gamble
PG
Mkt Cap336.58B
Procter & Gamble offers a wide range of consumer health and personal care products, competing in similar markets as Genomma Lab.
Bayer
BAYRY
Mkt Cap56.12B
Bayer AG's consumer health division produces over-the-counter drugs and nutritional supplements, competing with Genomma Lab's product portfolio.
GSK
GSK
Mkt Cap94.23B
GlaxoSmithKline, with its consumer healthcare division, competes in the over-the-counter medication market, similar to Genomma Lab.
Pfizer
PFE
Mkt Cap158.45B
Pfizer has a consumer healthcare division that produces over-the-counter medications, directly competing with Genomma Lab's offerings.
Novartis
NVS
Mkt Cap268B
Novartis operates in the pharmaceuticals sector, including over-the-counter drugs, competing with Genomma Lab's range of products.
Sanofi
SNY
Mkt Cap95.65B
Sanofi offers a broad portfolio of over-the-counter products, competing in the same space as Genomma Lab.
Merck
MRK
Mkt Cap356.01B
Merck, through its various healthcare products, competes in the pharmaceutical and consumer health markets, overlapping with Genomma Lab's market.
Abbvie
ABBV
Mkt Cap464.43B
AbbVie, with its focus on pharmaceuticals, has a range of products that compete in the healthcare sector alongside Genomma Lab.
Church & Dwight
CHD
Mkt Cap22.37B
Church & Dwight offers a variety of household and personal care products, competing in the consumer goods sector alongside Genomma Lab.

About

Genomma Lab Internacional, S.A.B. de C.V., alongside its various operating units, specializes in the creation, promotion, and distribution of a wide array of over-the-counter (OTC) pharmaceutical goods and personal care items. Its operations span across Mexico and numerous international markets. The company's extensive product portfolio addresses diverse consumer needs, encompassing categories such as skincare, hair care, general health and wellness solutions, and pain management. Specific offerings include remedies for coughs and colds, digestive health aids, sexual well-being products, antiperspirants and deodorants, hand sanitizers, isotonic beverages, and shaving essentials. Beyond these, it also markets specialized pharmaceuticals such as analgesics, antifungals, and treatments for hemorrhoids. These products are brought to market under a multitude of well-known brands, including Cicatricure, Asepxia, Teatrical, Goicoechea, Sistema GB, Medicasp, Tío Nacho, Vanart, Novamil, Ultra Bengue, X-Ray, Tafirol, Alliviax, Bufferin, Next, XL-3, Genoprazol, QG5, Kaopectate, Proctan, Nikzon, Unesia, Silka Medic, lagicam, Suerox, Groomen, DiabetTX, among others. Established in 1996, Genomma Lab Internacional, S.A.B. de C.V. maintains its corporate headquarters in Mexico City, Mexico.
Show More
CEO
Juan Marco Sparvieri
Employees
1465
Country
Mexico
ISIN
MX01LA010006
WKN
000A0Q4TC

Listings

0 Comments

Share your thoughts

FAQs

What is Genomma Lab Internacional SAB stock price today?▼
The current price of GNMLF is $0.72 USD — it has increased by +0% in the past 24 hours. Watch Genomma Lab Internacional SAB stock price performance more closely on the chart.
What is Genomma Lab Internacional SAB stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Genomma Lab Internacional SAB stocks are traded under the ticker GNMLF.
Is Genomma Lab Internacional SAB stock price growing?▼
GNMLF stock has fallen by -1.01% compared to the previous week, the month change is a -6.28% fall, over the last year Genomma Lab Internacional SAB has showed a -22.74% decrease.
What is Genomma Lab Internacional SAB market cap?▼
Today Genomma Lab Internacional SAB has the market capitalization of 722.2M
What is Genomma Lab Internacional SAB revenue for the last year?▼
Genomma Lab Internacional SAB revenue for the last year amounts to 1.15B USD.
What is Genomma Lab Internacional SAB net income for the last year?▼
GNMLF net income for the last year is 103.21M USD.
Does Genomma Lab Internacional SAB pay dividends?▼
Yes, GNMLF dividends are paid quarterly. The last dividend per share was 0.01 . As of today, Dividend Yield (FWD)% is 6.13%.
How many employees does Genomma Lab Internacional SAB have?▼
As of October 21, 2026, the company has 1,465 employees.
In which sector is Genomma Lab Internacional SAB located?▼
Genomma Lab Internacional SAB operates in the Health & Wellness sector.
When did Genomma Lab Internacional SAB complete a stock split?▼
The last stock split for Genomma Lab Internacional SAB was on August 3, 2010 with a ratio of 2:1.
Where is Genomma Lab Internacional SAB headquartered?▼
Genomma Lab Internacional SAB is headquartered in Mexico City, Mexico.